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Abstract: 
The inappropriate drug use during the pregnancy may cause serious complications. However, the consumption 
of drugs during the pregnancy cannot be totally avoided because of the existing chronic illness that may require 
continuous treatment or the development of new medical conditions during pregnancy that require therapeutic 
intervention. The main objective of this study was to evaluate the awareness about the drug safety and 
medication use among the pregnant women of the Northern Border Region of the Kingdom of Saudi Arabia. 
This cross-sectional study was carried out using a pretested and structured questionnaire among the pregnant 
women (N = 50) of the rural area, near Arar City and Rafha City, of the Northern Border Region of the 
Kingdom of Saudi Arabia. The data obtained was analyzed using the Statistical Package for Social Sciences 
(SPSS) version 19.  It was surprising to note that neither doctors nor the pharmacists provided full information 
about the medicine to more than 3/4
th
 of the patients. This type of practice by the doctors and pharmacist may 
pose pregnancy related problems to the expecting mothers and may lead to serious consequences. There is an 
urgent need to take remedial actions regarding this issue by the concerned authorities of the Northen Border 
Region of the Kingdom of Saudi Arabia. 
Keywords: Awareness, Safety, Drug, Pregnancy, Northern Border, Saudi Arabia. 
Corresponding Author: 
Abida, 
Department of Pharmaceutical Chemistry,  
Faculty of Pharmacy,  
Northern Border University, Rafha - 91911,  
P.O. BOX 840, Kingdom of Saudi Arabia. 
E-mail: aqua_abkhan@yahoo.com. 
Mobile Number: +966599577935 
 
Please cite this article in press as Abida et al,  Awareness about the Drug Safety and Medication use among 
the Pregnant Women of the Northern Border Region of Saudi Arabia, Indo Am. J. P. Sci, 2016; 3(9). 
QR code 
 
IAJPS 2016, 3 (9), 1054-1061                                    Abida et al                                 ISSN 2349-7750 
 
w w w . i a j p s . c o m  
 
Page 1055 
INTRODUCTION: 
The issue of the awareness about the drug safety 
and medication use among the pregnant women has 
become a public health issue after the thalidomide 
tragedy [1,2]. During pregnancy, the drug intake is 
of great concern because drug taken during the 
pregnancy may cross placenta and may produce its 
teratogenic effects on the foetus [3]. Despite that 
the drug use during pregnancy may pose a 
teratogenic risk for the embryo, the consumption of 
drugs during pregnancy by the pregnant women 
cannot be totally avoided because of the existing 
chronic illness that may require continuous 
treatment or the development of new medical 
conditions during pregnancy that require 
therapeutic intervention [4]. Accordingly, the 
pregnant women take medication during their 
pregnancy; consume drugs, including prescription 
and non-prescription (OTC) medications as well as 
herbal products and dietary supplements [5]. 
According to one report, about 8% of the pregnant 
women worldwide need permanent drug treatment 
for chronic diseases such as diabetes, for acute 
illnesses such as influenza, or for treating 
pregnancy complications such as vomiting [3]. 
According to other reports, more than 50% of the 
pregnant women take at least one prescription or 
non-prescription drug during pregnancy their 
pregnancy [6,7]; over 90% of the pregnant women 
take three or four medicines at some stage of 
pregnancy [8]; and about 84% to 99% of the 
pregnant women use either prescribed or OTC 
drugs during pregnancy to treat acute or chronic 
conditions [9]. 
Many reports at global level about the drug use 
during the pregnancy have been published that 
reported inappropriate use of medications during 
pregnancy [10-18]. Recently, a report has been 
published in Saudi Arabia addressing similar issues 
[19]. However, this article was silent about the 
inclusion of the pregnant women of the Northern 
Border Region of Saudi Arabia. To the best of our 
knowledge, there are no data available about the 
awareness about the drug safety and medication use 
among the pregnant women of the Northern Border 
Region of the Kingdom of Saudi Arabia. Therefore, 
this study was planned with the expectations that it 
will help us to suggest some measures to be taken 
by the ministry of health to increase the awareness  
 
about the drug safety and medication use among 
the pregnant women of this region. 
 
MATERIALS AND METHODS: 
This cross-sectional study using a pretested and 
structured questionnaire was carried out from 
October 24, 2015 to January 21, 2016 among the 
pregnant women (N = 50) of the rural area, near 
Arar City and Rafha City, of the Northern Border 
Region of the Kingdom of Saudi Arabia. The 
questionnaire was developed according to the 
scientific literature and using the similar reports 
published worldwide [10-19]. The questionnaire 
included questions related to the socio-
demographic characteristics, pregnancy related 
information, awareness about the drug safety and 
medication use during pregnancy. The inclusion 
criteria were that participants should be Saudi, 
married and pregnant. All the participants had to be 
between the age of puberty years to 50 years and 
had to sign a written consent. To avoid double 
counting of participants, each participant was 
provided with a unique identification number. The 
identity of the participants was anonymized 
through the process of data analysis. The 
questionnaire was provided to each participant in 
English and/or Arabic language. The questionnaire 
was provided to the participants at the place of their 
choice. Informed consent was obtained from the 
participants after the study protocol was explained 
to them. The participants were assured of the 
anonymity and confidentiality of the information. 
The data obtained was analyzed using the 
Statistical Package for Social Sciences (SPSS) 
version 19.  
This study was a cross-sectional epidemiological 
study using a pretested and structured questionnaire 
and did not involve any risk to the participants. The 
participants were just asked to fill the questionnaire 
about their awareness regarding the medication use 
during pregnancy. Accordingly, this study did not 
require a review board approval. 
 
RESULTS: 
A total of 50 Saudi pregnant women in the rural 
area, near Arar City and Rafha City, of the 
Northern Border Region of Saudi Arabia were 
contacted for this study. The socio-demographic 
characteristics (N = 50) of these participants are 
provided in Table 1 and Figure 1. 
 
 
 
IAJPS 2016, 3 (9), 1054-1061                                    Abida et al                                 ISSN 2349-7750 
 
w w w . i a j p s . c o m  
 
Page 1056 
Table 1: Socio-demographic characteristics of the studied population (N = 50) 
Characteristics Percentage of pregnant 
Women 
Nationality  
Saudi 100% 
Non Saudi - 
Education  
Illiterate 16% 
Primary School 18% 
Higher Secondary School 28% 
University 38% 
Occupation  
Housewife 40% 
Healthcare employee 18% 
Employee 24% 
Others 18% 
Residence  
Rural 100% 
Urban 0% 
Parity  
First-time pregnant 28% 
1–3 previous children 32% 
More than 3 previous children 40% 
Previous abnormal children  
Yes 4% 
No 96% 
 
 
All the participants were Saudi pregnant females. The age of these participants ranged from 20 years to 45 
years. More than 66% (28%+38%) participants were literate; 18% were primary school passout; and 16% 
were illiterate. The majority of the participants were housewives 40%; 18% were healthcare related employees; 
24% were employees; and 18% were others. All the participants, 100%, belonged to rural area. About 72% of 
the pregnant women had 1 or more children. On the other hand 28% of the women were experiencing first time 
pregnancy. The majority of the participants, 96%, did not have abnormal children.   
The pregnancy related information  (N = 50) of these participants are provided in Table 2 and in Figure 2. 
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Table 2: Pregnancy related information of the studied population (N = 50) 
Information Percentage of pregnant 
Women 
Are you happy with this pregnancy?  
Yes 54% 
Not Bad 26% 
I don’t care 20% 
Do you regularly meet your doctor?  
Yes 46% 
No 24% 
Sometimes 30% 
Are you suffering from any chronic disease?  
Yes 32% 
No 68% 
Which trimester is the critical time for drug use during pregnancy?  
First 76% 
Second 2% 
Third 22% 
 
 
More than half of the respondents (54%) were happy with their pregnancy; 26% did not have a bad experience 
about their pregnancy; and about 20% did not care about their pregnancy. Only 46% of the pregnant women 
were regularly meeting with their doctor; 30% were not meeting their doctor regularly; and about 24% did not 
meet any doctor during their pregnancy. About 68% participants were not suffering from any chronic disease. 
The first trimester was found to be the critical time for drug use during pregnancy in 76% of the respondents.  
The data related to the awareness about the drug safety and medication use during pregnancy (N = 50) is 
provided in Table 3 and in Figure 3.1, 3.2 & 3.3. 
 
IAJPS 2016, 3 (9), 1054-1061                                    Abida et al                                 ISSN 2349-7750 
 
w w w . i a j p s . c o m  
 
Page 1058 
Table 3: Awareness about the drug safety and medication use during pregnancy among the studied 
population (N = 50) 
Question Percentage of pregnant 
Women 
 Yes No Sometimes 
Did you inform your doctor about your existing disease? 88% 12% - 
Did you inform about your existing and past medication 
history to the doctor?  
88% 12% - 
Are you taking any medicine prescribed by the doctor? 68% 32% - 
Did the doctor give sufficient information about the medicine? 26% 22% 52% 
Did you inform the pharmacist about your pregnancy?  60% 14% 26% 
Does the pharmacist give sufficient information about the 
medicine? 
12% 50% 38% 
Do you have confidence on the pharmacist? 70% 16% 14% 
Do you make sure about the medicine leaflet with your 
medicines? 
40% 32% 28% 
Do you read the contents of the medicine leaflet of your 
medicine carefully? 
44% 38% 18% 
Are you aware about the drugs that should be used during 
pregnancy? 
88% 12% - 
Do you use home remedies (medicinal herbs, minerals, etc.) 
during pregnancy? 
28% 44% 28% 
Did you face abortion because of any drug in the past? 16% 84% - 
Do drugs cause birth defects? 46% 12% 42% 
Who is the main source of awareness about the drug safety and medication use during pregnancy? 
Doctor 58% 
Pharmacist 20% 
Media 18% 
Others 4% 
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The data related to the main source of awareness about the drug safety and medication use during pregnancy to 
the pregnant women (N = 50) is provided in Table 4 and Figure 4. 
 
Table 4: The main source of awareness about the drug safety and medication use during pregnancy of the 
pregnant women (N = 50) 
Question Percentage of pregnant women 
Who is the main source of awareness about the drug 
safety and medication use during pregnancy? 
Doctor Pharmacist Media Others 
58% 20% 18% 4% 
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The data related to the awareness about the drug 
safety and medication use during pregnancy 
revealed that about 88% of the participants 
discussed about their existing disease and 
medication history with the doctor. About 68% 
participants were on current medication prescribed 
by the doctor. However, the doctor provided 
sufficient information about the medicines to 25% 
patients only. In pharmacy, about 60% participants 
informed the pharmacist about their pregnancy. 
However, the pharmacist provided sufficient 
information about the medicines to 12% patients 
only. More than 70% of the respondents stated that 
they had confidence on the pahramcist. Only about 
About 45% of the participants ensured about the 
medicine leaflet and read it. The data indicate that 
about 88% of the participants were about their 
drugs; 84% did not face abortion problems with 
their drugs; and more than 46% were aware that 
drugs can cause birth defects. About 28% women 
were using home remedies during their pregnancy. 
Regarding the source of awareness about the drug 
safety and medication during pregnancy, 58% 
participants got awareness about their drug from 
doctors; 20% from the pharmacist; 18% media; and 
4% from other sources. 
 
DISCUSSION: 
This study has provided a very significant insight 
about the level of awareness about the drug safety 
and medication use among the pregnant women of 
the Northern Border Region of Saudi Arabia. This 
study has revealed that most of the pregnant 
women are aware of the importance of their visit to 
the doctor and pharmacist for the consultation. 
Interestingly, most of the participants were 
reluctant or unsure about the use of herbal 
remedies. This was reflected by low percent of 
herbal users (28%). Many herbal remedies are 
traditionally used for symptoms that occur 
commonly during pregnancy, such as nausea and 
vomiting. However, the use of herbal remedies 
during pregnancy is of concern. Herbal remedies 
may contain compounds that can lead to 
miscarriage, premature birth, uterine contractions, 
or injury to the foetus [20]. Thus, it is important to 
understand the extent to which herbs are used in 
pregnancy, the specific products used and the 
reasons for which they are used [21]. The 
prescription of appropriate medicine to the 
pregnant women poses a great challenge to the 
physician as well as to the pharmacist. The 
physician and pharmacist must consider the risk-
benefit relation for both the mother and the fetus 
[1,22,23]. This study has also indicated that the 
main sources of awareness about the drug safety 
and medication use are doctors, pharmacists, and 
media. However, it was surprising to note that 
neither doctors nor the pharmacists provided full 
information about the medicine to more than 3/4
th
 
of the patients. This type of practice by the doctors 
and pharmacist may pose pregnancy related 
problems to the expecting mothers and may lead to 
serious consequences. A Pharmacist is expected to 
provide his expert advice to the patients regarding 
the prescribed medicine .e.g. dose, frequency, route 
of administration, possible side effects, drug-food 
interaction, drug-drug interaction, patient 
counselling, etc.. Accordingly, this area needs 
improvement and remedial actions should be taken 
by the concerned authority to address this issue in 
future. 
 
CONCLUSION: 
This study has revealed that during pregnancy, the 
women of the Northen Border Region of Saudi 
Arabia did not get sufficient information regarding 
their medicine from doctor or pharmacist. This may 
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lead to serious consequences for expecting 
mothers. There is an urgent need to take remedial 
actions regarding this issue by the concerned 
authorities of the Northen Border Region.  
 
LIMITATION OF THE STUDY: 
The first limitation of this survey was its number of 
participants. Secondly, the major participation by 
literate women that might have influenced the 
analysis in terms of the participant’s awareness 
about their medicine. Thirdly, the major 
participation of the multiparous women who got 
knowledge about the drug from their previous 
experiences. Therefore, the results obtained from 
this study cannot be generalized to the whole 
population of pregnant women present in the 
Northen Border Region of Saudi Arabia. 
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